Biohaven Therapeutics Ltd.

This study tested the long-term safety of the drug BHV-7000 in 94 adults with bipolar I disorder. Participants had to have finished an earlier study first. The trial was stopped early, and researchers tracked side effects like lab abnormalities and heart changes. The goal was to …

This study tested whether adding an experimental drug called BHV-7000 to a patient's current anti-seizure medications could better control severe, full-body seizures in adults with a specific type of epilepsy. The trial was designed to compare the drug to a placebo (inactive pill…